Furthermore, we seek to determine those SLCs that may influence patient survival and those associated with PD-L1 expression across all SLC genes in 34 TCGA cancer types, encompassing both solid tumors and hematologic malignancies (Table S1). This evidence concerns the gene CCL21 and cancer.